MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamada, M.
Right arrow Articles by Richelson, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, M.
Right arrow Articles by Richelson, E.

Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells

M Yamada, M Yamada, MA Watson and E Richelson

Department of Psychiatry and Psychology, Mayo Foundation, Jacksonville, Florida 32224.

The tridecapeptide neurotensin is a putative neurotransmitter in the central nervous system. Previously, we showed that the rat neurotensin receptor expressed in CHO-K1 cells mediates polyphosphoinositide hydrolysis and cAMP formation. To further investigate these neurotensin receptor-mediated signal transduction systems, we constructed three deletion mutations in the putative third intracellular loop of this receptor and transfected these mutated genes into CHO-K1 cells. The equilibrium dissociation constants for specific [3H]neurotensin binding to these mutants were not different from that for the wild-type receptor. However, one mutant, which lacked 27 amino acids (amino acids 270-296), did not stimulate polyphosphoinositide hydrolysis, whereas it retained its ability to stimulate cAMP formation. In addition, as found for the wild-type receptor, sequestration occurred with this mutant. We demonstrated here that the putative third intracellular loop of this receptor plays a role in coupling to certain G proteins that induce polyphosphoinositide hydrolysis but not in coupling to cAMP formation or in ligand binding. The two different signal transduction systems may be induced by different G proteins that couple at different sites of the neurotensin receptor protein in CHO-K1 cells. Furthermore, our data show that neurotensin receptor sequestration is independent of agonist- induced polyphosphoinositide hydrolysis.

Volume 46, Issue 3, pp. 470-476, 09/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurosci.Home page
F. St-Gelais, M. Legault, M.-J. Bourque, P.-P. Rompre, and L.-E. Trudeau
Role of Calcium in Neurotensin-Evoked Enhancement in Firing in Mesencephalic Dopamine Neurons
J. Neurosci., March 10, 2004; 24(10): 2566 - 2574.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Skrzydelski, A.-M. Lhiaubet, A. Lebeau, P. Forgez, M. Yamada, E. Hermans, W. Rostene, and D. Pelaprat
Differential Involvement of Intracellular Domains of the Rat NTS1 Neurotensin Receptor in Coupling to G Proteins: A Molecular Basis for Agonist-Directed Trafficking of Receptor Stimulus
Mol. Pharmacol., August 1, 2003; 64(2): 421 - 429.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Martin, J.-P. Vincent, and J. Mazella
Recycling ability of the mouse and the human neurotensin type 2 receptors depends on a single tyrosine residue
J. Cell Sci., January 1, 2002; 115(1): 165 - 173.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. Richard, S. Barroso, J. Martinez, C. Labbe-Jullie, and P. Kitabgi
Agonism, Inverse Agonism, and Neutral Antagonism at the Constitutively Active Human Neurotensin Receptor 2
Mol. Pharmacol., December 1, 2001; 60(6): 1392 - 1398.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Barroso, F. Richard, D. Nicolas-Etheve, J.-L. Reversat, J.-M. Bernassau, P. Kitabgi, and C. Labbe-Jullie
Identification of Residues Involved in Neurotensin Binding and Modeling of the Agonist Binding Site in Neurotensin Receptor 1
J. Biol. Chem., January 7, 2000; 275(1): 328 - 336.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Sarret, D. Nouel, C. Dal Farra, J.-P. Vincent, A. Beaudet, and J. Mazella
Receptor-mediated Internalization Is Critical for the Inhibition of the Expression of Growth Hormone by Somatostatin in the Pituitary Cell Line AtT-20
J. Biol. Chem., July 2, 1999; 274(27): 19294 - 19300.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. C. Howlett, C. Song, B. A. Berglund, G. H. Wilken, and J. J. Pigg
Characterization of CB1 Cannabinoid Receptors Using Receptor Peptide Fragments and Site-Directed Antibodies
Mol. Pharmacol., March 1, 1998; 53(3): 504 - 510.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
M. Margeta-Mitrovic, J. J. Grigg, K. Koyano, Y. Nakajima, and S. Nakajima
Neurotensin and Substance P Inhibit Low- and High-Voltage-Activated Ca2+ Channels in Cultured Newborn Rat Nucleus Basalis Neurons
J Neurophysiol, September 1, 1997; 78(3): 1341 - 1352.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Verrall, M. Ishii, M. Chen, L. Wang, T. Tram, and S. R. Coughlin
The Thrombin Receptor Second Cytoplasmic Loop Confers Coupling to Gq-like G Proteins in Chimeric Receptors. ADDITIONAL EVIDENCE FOR A COMMON TRANSMEMBRANE SIGNALING AND G PROTEIN COUPLING MECHANISM IN G PROTEIN-COUPLED RECEPTORS
J. Biol. Chem., March 14, 1997; 272(11): 6898 - 6902.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Le, K. Groshan, X. P. Zeng, and E. Richelson
Characterization of the Genomic Structure, Promoter Region, and a Tetranucleotide Repeat Polymorphism of the Human Neurotensin Receptor Gene
J. Biol. Chem., January 10, 1997; 272(2): 1315 - 1322.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Horstmeyer, H. Cramer, T. Sauer, W. Muller-Esterl, and C. Schroeder
Palmitoylation of Endothelin Receptor A. DIFFERENTIAL MODULATION OF SIGNAL TRANSDUCTION ACTIVITY BY POST-TRANSLATIONAL MODIFICATION
J. Biol. Chem., August 23, 1996; 271(34): 20811 - 20819.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-P. Pang, B. Cusack, K. Groshan, and E. Richelson
Proposed Ligand Binding Site of the Transmembrane Receptor for Neurotensin(8-13)
J. Biol. Chem., June 21, 1996; 271(25): 15060 - 15068.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. G. Eason and S. B. Liggett
Chimeric Mutagenesis of Putative G-protein Coupling Domains of the alpha 2A-Adrenergic Receptor. LOCALIZATION OF TWO REDUNDANT AND FULLY COMPETENT G
J. Biol. Chem., May 31, 1996; 271(22): 12826 - 12832.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Nakamura, C. Sakanaka, Y. Aoki, H. Ogasawara, T. Tsuji, H. Kodama, T. Matsumoto, T. Shimizu, and M. Noma
Identification of Two Isoforms of Mouse Neuropeptide Y-Y1 Receptor Generated by Alternative Splicing
J. Biol. Chem., December 15, 1995; 270(50): 30102 - 30110.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. G. Eason and S. B. Liggett
Identification of a G(s) Coupling Domain in the Amino Terminus of the Third Intracellular Loop of the alpha[IMAGE]-Adrenergic Receptor
J. Biol. Chem., October 20, 1995; 270(42): 24753 - 24760.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics